Saturday, January 28, 2023

Tag: anti-psychotics

Dr. Joseph Firth: The Role of Exercise and Nutrition in Early...

9
Dr. Joseph Firth of Western Sydney University talks about his research into the role of exercise and nutrition in supporting young people in the early stages of psychotic illness.

“Jury Smacks J&J with $70M in Damages in Latest Risperdal Breast...

0
Fierce Pharma reports: "Johnson & Johnson ($JNJ) is fighting more than 1,500 legal claims that its antipsychotic Risperdal triggered breast development in boys, and...

Diagnosisgate: A Major Media Blackout Mystery

34
Remember “Colonel Mustard in the kitchen with the candlestick”? From the game called “Clue” in which you tried to solve a murder mystery? There’s a current, all-too-true and serious mystery involving devastating consequences – even death – for uncounted but vast numbers of people, but in this one the culprits are known to a very few, while their motives remain mysterious. The story starts in 1995, when the man widely considered the world’s most important psychiatrist split a payoff of nearly one million dollars with two colleagues in exchange for doing two patently unethical and illegal things that created the groundwork for a major drug company to market falsely one of the most dangerous psychoactive drugs.

The Use of Antipsychotic Medications in Children

30
Since the mid-1990s antipsychotic medications have been increasingly prescribed for children, adolescents, and adults. The most recent report finds an increase in use for older children from 2006 to 2008. Most of the prescriptions of antipsychotics for children reported by the study were for conditions which had not been approved by the FDA (called off-label use).

The Once and Future Abilify: Depot Injections for Everyone?

21
This column is partly a report on the marketing of Abilify, the atypical antipsychotic that has become America’s best-selling drug.   It’s also an appeal for advice and feedback from the RxISK and Mad in America communities, and a call for some brainstorming about strategy.  The plans laid out by drugmakers Otsuka and Lundbeck for Abilify’s future, and the cooperation they’re getting from leading universities, are alarming enough to me that reporting on them seems inadequate.  We need action, although I’m not sure exactly what kind.

Psych Meds Put 49 Million Americans at Risk for Cancer

31
With 1 in 5 Americans taking a psychiatric medication, most of whom, long term, we should probably start to learn a bit more about them. In fact, it would have been in the service of true informed consent to have investigated long-term risks before the deluge of these meds seized our population over the past thirty years.

Sheller’s Appeal Demonstrates FDA’s Indifference to Drug Harm

21
As I wrote in Let’s All Support Stephen Sheller’s FDA Petition to Revoke the Pediatric Approval of Risperdal, Stephen Sheller's law firm, which represents hundreds of boys who were prescribed Risperdal and then grew breasts (gynecomastia) as a result, filed a petition with the Food and Drug Administration (FDA) to change the label and revoke its approval for use on children. During the course of discovery for litigation in its Risperdal cases, Sheller became privy to documents not provided to the FDA that showed Johnson & Johnson hid the problem. This is a very important case. If it is successful, it will give hope of forcing the FDA to follow its mandate to protect the public from harmful drugs.

The Biochemical Basis for “Mental Illness” – Finally Solved!

3
I wanted to explain to you the biochemical and genetic and epigentic basis for all "mental illness." I want you to know that I...